 | • レポートコード：B-GIR08C5703 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、テノホビル/エムトリシタビン配合剤の世界市場について調べ、まとめました。種類別セグメントは、自己制作API、APIアウトソーシング等、用途別セグメントは、石油及びガス生産、送電、その他等に区分しました。テノホビル/エムトリシタビン配合剤の世界市場概観、企業動向、企業別テノホビル/エムトリシタビン配合剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・テノホビル/エムトリシタビン配合剤の市場概観 ・テノホビル/エムトリシタビン配合剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・テノホビル/エムトリシタビン配合剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・テノホビル/エムトリシタビン配合剤の世界市場規模 ・テノホビル/エムトリシタビン配合剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・テノホビル/エムトリシタビン配合剤のアメリカ市場規模推移 ・テノホビル/エムトリシタビン配合剤のカナダ市場規模推移 ・テノホビル/エムトリシタビン配合剤のメキシコ市場規模推移 ・テノホビル/エムトリシタビン配合剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・テノホビル/エムトリシタビン配合剤のドイツ市場規模推移 ・テノホビル/エムトリシタビン配合剤のイギリス市場規模推移 ・テノホビル/エムトリシタビン配合剤のロシア市場規模推移 ・テノホビル/エムトリシタビン配合剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・テノホビル/エムトリシタビン配合剤の日本市場規模推移 ・テノホビル/エムトリシタビン配合剤の中国市場規模推移 ・テノホビル/エムトリシタビン配合剤の韓国市場規模推移 ・テノホビル/エムトリシタビン配合剤のインド市場規模推移 ・テノホビル/エムトリシタビン配合剤の東南アジア市場規模推移 ・テノホビル/エムトリシタビン配合剤の南米市場分析（ブラジル、アルゼンチン等） ・テノホビル/エムトリシタビン配合剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・テノホビル/エムトリシタビン配合剤の種類別分析/販売量、売上、市場シェア（自己制作API、APIアウトソーシング） ・テノホビル/エムトリシタビン配合剤の用途別分析/市場規模（石油及びガス生産、送電、その他） ・テノホビル/エムトリシタビン配合剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・テノホビル/エムトリシタビン配合剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Tenofovir/Emtricitabine Combination Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Gilead Sciences
Cipla
Mylan Pharmaceuticals
Emcure Pharmaceuticals
Hetero Drugs
Veritaz Healthcare
Sun Pharmaceutical Industries
Alkem Laboratories
Teva
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Self-production API
Outsourcing of API
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tenofovir/Emtricitabine Combination Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tenofovir/Emtricitabine Combination Drug, with price, sales, revenue and global market share of Tenofovir/Emtricitabine Combination Drug in 2017 and 2018.
Chapter 3, the Tenofovir/Emtricitabine Combination Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tenofovir/Emtricitabine Combination Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Tenofovir/Emtricitabine Combination Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Tenofovir/Emtricitabine Combination Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Tenofovir/Emtricitabine Combination Drug Introduction
1.2 Market Analysis by Type
1.2.1 Self-production API
1.2.2 Outsourcing of API
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Business Overview
2.1.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Sciences Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Cipla
2.2.1 Business Overview
2.2.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cipla Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mylan Pharmaceuticals
2.3.1 Business Overview
2.3.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Pharmaceuticals Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Emcure Pharmaceuticals
2.4.1 Business Overview
2.4.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Emcure Pharmaceuticals Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Hetero Drugs
2.5.1 Business Overview
2.5.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hetero Drugs Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Veritaz Healthcare
2.6.1 Business Overview
2.6.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Veritaz Healthcare Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sun Pharmaceutical Industries
2.7.1 Business Overview
2.7.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sun Pharmaceutical Industries Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Alkem Laboratories
2.8.1 Business Overview
2.8.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Alkem Laboratories Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Teva
2.9.1 Business Overview
2.9.2 Tenofovir/Emtricitabine Combination Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Tenofovir/Emtricitabine Combination Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Tenofovir/Emtricitabine Combination Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Tenofovir/Emtricitabine Combination Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Tenofovir/Emtricitabine Combination Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Tenofovir/Emtricitabine Combination Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Tenofovir/Emtricitabine Combination Drug Market Analysis by Regions
4.1 Global Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Tenofovir/Emtricitabine Combination Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Tenofovir/Emtricitabine Combination Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
4.3 Europe Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
4.5 South America Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
5 North America Tenofovir/Emtricitabine Combination Drug by Country
5.1 North America Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Market Share by Country
5.1.1 North America Tenofovir/Emtricitabine Combination Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Tenofovir/Emtricitabine Combination Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
5.3 Canada Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
6 Europe Tenofovir/Emtricitabine Combination Drug by Country
6.1 Europe Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Tenofovir/Emtricitabine Combination Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Tenofovir/Emtricitabine Combination Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
6.3 UK Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
6.4 France Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
6.5 Russia Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
6.6 Italy Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Tenofovir/Emtricitabine Combination Drug by Country
7.1 Asia-Pacific Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Tenofovir/Emtricitabine Combination Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Tenofovir/Emtricitabine Combination Drug Revenue and Market Share by Country (2014-2019)
7.2 China Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
7.3 Japan Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
7.4 Korea Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
7.5 India Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
8 South America Tenofovir/Emtricitabine Combination Drug by Country
8.1 South America Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Market Share by Country
8.1.1 South America Tenofovir/Emtricitabine Combination Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Tenofovir/Emtricitabine Combination Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Tenofovir/Emtricitabine Combination Drug by Countries
9.1 Middle East and Africa Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Tenofovir/Emtricitabine Combination Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Tenofovir/Emtricitabine Combination Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
10 Global Tenofovir/Emtricitabine Combination Drug Market Segment by Type
10.1 Global Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Tenofovir/Emtricitabine Combination Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Tenofovir/Emtricitabine Combination Drug Revenue and Market Share by Type (2014-2019)
10.2 Self-production API Sales Growth and Price
10.2.1 Global Self-production API Sales Growth (2014-2019)
10.2.2 Global Self-production API Price (2014-2019)
10.3 Outsourcing of API Sales Growth and Price
10.3.1 Global Outsourcing of API Sales Growth (2014-2019)
10.3.2 Global Outsourcing of API Price (2014-2019)
11 Global Tenofovir/Emtricitabine Combination Drug Market Segment by Application
11.1 Global Tenofovir/Emtricitabine Combination Drug Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Drug Center Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
12.1 Global Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Tenofovir/Emtricitabine Combination Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
12.2.2 Europe Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
12.2.4 South America Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
12.3 Tenofovir/Emtricitabine Combination Drug Market Forecast by Type (2019-2024)
12.3.1 Global Tenofovir/Emtricitabine Combination Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Tenofovir/Emtricitabine Combination Drug Market Share Forecast by Type (2019-2024)
12.4 Tenofovir/Emtricitabine Combination Drug Market Forecast by Application (2019-2024)
12.4.1 Global Tenofovir/Emtricitabine Combination Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Tenofovir/Emtricitabine Combination Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Tenofovir/Emtricitabine Combination Drug Picture
Table Product Specifications of Tenofovir/Emtricitabine Combination Drug
Figure Global Sales Market Share of Tenofovir/Emtricitabine Combination Drug by Types in 2018
Table Tenofovir/Emtricitabine Combination Drug Types for Major Manufacturers
Figure Self-production API Picture
Figure Outsourcing of API Picture
Figure Tenofovir/Emtricitabine Combination Drug Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Figure United States Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure France Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure UK Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure China Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure India Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Tenofovir/Emtricitabine Combination Drug Revenue (Value) and Growth Rate (2014-2024)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Gilead Sciences Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Cipla Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Mylan Pharmaceuticals Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Mylan Pharmaceuticals Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Emcure Pharmaceuticals Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Emcure Pharmaceuticals Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Hetero Drugs Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Veritaz Healthcare Basic Information, Manufacturing Base and Competitors
Table Veritaz Healthcare Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Veritaz Healthcare Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Industries Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Sun Pharmaceutical Industries Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Alkem Laboratories Basic Information, Manufacturing Base and Competitors
Table Alkem Laboratories Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Alkem Laboratories Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Tenofovir/Emtricitabine Combination Drug Type and Applications
Table Teva Tenofovir/Emtricitabine Combination Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Tenofovir/Emtricitabine Combination Drug Sales by Manufacturer (2017-2018)
Figure Global Tenofovir/Emtricitabine Combination Drug Sales Market Share by Manufacturer in 2017
Figure Global Tenofovir/Emtricitabine Combination Drug Sales Market Share by Manufacturer in 2018
Table Global Tenofovir/Emtricitabine Combination Drug Revenue by Manufacturer (2017-2018)
Figure Global Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Manufacturer in 2017
Figure Global Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Manufacturer in 2018
Figure Top 3 Tenofovir/Emtricitabine Combination Drug Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Tenofovir/Emtricitabine Combination Drug Manufacturer (Revenue) Market Share in 2018
Figure Global Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Global Tenofovir/Emtricitabine Combination Drug Revenue and Growth Rate (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Sales by Regions (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Sales Market Share by Regions (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Revenue by Regions (2014-2019)
Figure Global Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Regions (2014-2019)
Figure Global Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Regions in 2018
Figure North America Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Europe Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure South America Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure North America Tenofovir/Emtricitabine Combination Drug Revenue and Growth Rate (2014-2019)
Table North America Tenofovir/Emtricitabine Combination Drug Sales by Countries (2014-2019)
Table North America Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries (2014-2019)
Figure North America Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries (2014-2019)
Figure North America Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries in 2018
Table North America Tenofovir/Emtricitabine Combination Drug Revenue by Countries (2014-2019)
Table North America Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure North America Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure North America Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries in 2018
Figure United States Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Canada Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Mexico Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Europe Tenofovir/Emtricitabine Combination Drug Revenue and Growth Rate (2014-2019)
Table Europe Tenofovir/Emtricitabine Combination Drug Sales by Countries (2014-2019)
Table Europe Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries (2014-2019)
Table Europe Tenofovir/Emtricitabine Combination Drug Revenue by Countries (2014-2019)
Figure Europe Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries in 2018
Figure Germany Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure UK Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure France Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Russia Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Italy Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Tenofovir/Emtricitabine Combination Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Tenofovir/Emtricitabine Combination Drug Sales by Countries (2014-2019)
Table Asia-Pacific Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries 2018
Table Asia-Pacific Tenofovir/Emtricitabine Combination Drug Revenue by Countries (2014-2019)
Figure Asia-Pacific Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries 2018
Figure China Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Japan Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Korea Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure India Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Southeast Asia Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure South America Tenofovir/Emtricitabine Combination Drug Revenue and Growth Rate (2014-2019)
Table South America Tenofovir/Emtricitabine Combination Drug Sales by Countries (2014-2019)
Table South America Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries (2014-2019)
Figure South America Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries in 2018
Table South America Tenofovir/Emtricitabine Combination Drug Revenue by Countries (2014-2019)
Table South America Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure South America Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries in 2018
Figure Brazil Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Argentina Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Colombia Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Tenofovir/Emtricitabine Combination Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Tenofovir/Emtricitabine Combination Drug Sales by Countries (2014-2019)
Table Middle East and Africa Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Tenofovir/Emtricitabine Combination Drug Sales Market Share by Countries in 2018
Table Middle East and Africa Tenofovir/Emtricitabine Combination Drug Revenue by Countries (2014-2019)
Table Middle East and Africa Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Tenofovir/Emtricitabine Combination Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure UAE Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Egypt Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure Nigeria Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Figure South Africa Tenofovir/Emtricitabine Combination Drug Sales and Growth Rate (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Sales by Type (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Sales Share by Type (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Revenue by Type (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Revenue Share by Type (2014-2019)
Figure Global Self-production API Sales Growth (2014-2019)
Figure Global Self-production API Price (2014-2019)
Figure Global Outsourcing of API Sales Growth (2014-2019)
Figure Global Outsourcing of API Price (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Sales by Application (2014-2019)
Table Global Tenofovir/Emtricitabine Combination Drug Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Growth Rate (2019-2024)
Table Global Tenofovir/Emtricitabine Combination Drug Sales Forecast by Regions (2019-2024)
Table Global Tenofovir/Emtricitabine Combination Drug Market Share Forecast by Regions (2019-2024)
Figure North America Sales Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
Figure Europe Sales Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
Figure Asia-Pacific Sales Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
Figure South America Sales Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
Figure Middle East and Africa Sales Tenofovir/Emtricitabine Combination Drug Market Forecast (2019-2024)
Table Global Tenofovir/Emtricitabine Combination Drug Sales Forecast by Type (2019-2024)
Table Global Tenofovir/Emtricitabine Combination Drug Market Share Forecast by Type (2019-2024)
Table Global Tenofovir/Emtricitabine Combination Drug Sales Forecast by Application (2019-2024)
Table Global Tenofovir/Emtricitabine Combination Drug Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
エファビレンツ/テノホビル/エムトリシタビン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Efavirenz/Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report foc…- エルビテグラビル/コビシスタット/エムトリシタビン/テノホビルアラフェンアミド併用薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Resear…
- エムトリシタビン/リルピビリン/テノホビルアラフェンアミドの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Emtricitabine/Rilpivirine/Tenofovir Alafenamide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuse…
- テノホビルアラフェンアミド及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Tenofovir Alafenamide and Its Combination Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…
- ドルテグラビル/リルピビリン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir/Rilpivirine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on t…